Molecular Devices Returns to Life Sciences Marketplace

New Brand Launched by Molecular Devices, Inc.

SUNNYVALE, California, February 3 - Today, Molecular Devices, Inc.-now part of Danaher
Corporation-re-launched the Molecular Devices brand into the life sciences
marketplace. The renewed corporate brand is focused primarily on meeting
customer needs and exceeding customer expectations, and includes an evolved
visual identity system. A new logo illustrates the company's commitment to
provide high-performance analytical technologies that support the scientific
success of its customers: the company's instrument-the customer's biology.

First introduced more than 25 years ago, the Molecular Devices brand has
earned increasing value in life sciences markets, becoming a well-recognized
and sought-after brand for analytical instrumentation. Now, as part of the
Danaher Medical Technologies segment, Molecular Devices, Inc. is focused on
renewing its brand, seeking to retain and rebuild many of its historical
attributes while adding new ones that translate into direct value for
customers.

"Our employees are excited about a new Molecular Devices brand that is
focused primarily on serving our customers to the best of our abilities,"
said Tom Olenic, Vice President and General Manager for Molecular Devices,
Inc. "The acquisition has given us a chance to take a close look at the way
we do business and, in doing so, to identify the way we could be doing
business-it's a tremendous opportunity, and we are definitely taking full
advantage of it."

Going forward, Molecular Devices will have a singular focus-its
customers. Whether a long-time user, recent adopter, or prospective customer,
their needs will fuel the company's actions. By hiring and retaining
creative, best-in-class people, Molecular Devices will continue to design,
manufacture, and commercialize analytical instruments, software, and assays
to support the scientific success of its customers, regardless of objective:
publication, compound hits, lead compounds, new molecular entity, bioassay,
biotest, etc. The company will also provide dedicated, follow-on support to
ensure that customer needs and expectations continue to be met over time.

According to Tom Driscoll, Vice President of Global Marketing for
Molecular Devices, Inc., "Understanding each customer's unique laboratory
workflow continues to be a top priority, and we will direct product
development efforts toward solving customer issues and optimizing customer
workflows. Our goal now, as a new Molecular Devices brand, is to deliver
highly relevant analytical products and services to detect biology, decode
data, and drive successful life science discovery in both applied and basic
research environments."

Today, the Molecular Devices brand includes specialized products,
services, and expertise for microplate, microarray, and label-free analysis;
high-content and research imaging; automated and conventional
electrophysiology; cellular screening; laser capture microdissection; and
contaminant detection. Its products offer a full range of detection
technologies and can meet all throughput needs to help drive success in basic
research-from molecular to cellular to systems biology-as well as applied
research-from discovery to development to production of new drugs, vaccines,
and tests.

Some of the business' top product brands, which will also undergo renewal
this year, include: SpectraMax(R), ImageXpress(R), Axon(TM), IonWorks(R),
Threshold(R), CellKey(TM), FLIPR(R), and Arcturus(R).

About Molecular Devices, Inc.

Founded in 1983, Molecular Devices Corporation introduced its first
microplate reader in 1987 and has continually broadened its product and
service portfolio through a combination of internal research and development
and strategic acquisitions, including Universal Imaging Corporation (2002),
Axon Instruments (2004), and Blueshift Biotechnologies, Inc. (2006). In 2007,
Molecular Devices Corporation was acquired by MDS Inc. and integrated into
its MDS Analytical Technologies division. And, in 2010, the business was
acquired by Danaher Corporation and now operates independently as part of its
Medical Technologies segment. Molecular Devices, Inc. designs, develops, and
commercializes high-performance analytical instruments, software, and
reagents to help drive success in basic life sciences research, drug
discovery, biologics development and production, and bioassay and biotest
development. The business is in the process of returning a renewed,
independent Molecular Devices brand to the life sciences marketplace, with a
focus on delivering unique value to customers. More information can be found
at www.MolecularDevices.com.

Molecular Devices(R), the Molecular Devices logo, SpectraMax(R),
ImageXpress(R), Axon(TM), IonWorks(R), Threshold(R), CellKey(TM), FLIPR(R),
Arcturus(R), and all other trademarks are the property of Molecular Devices,
Inc.

Lisa English, PhD, APR; Director, Communications, Molecular Devices, Inc., +1-408-747-3630, lisa.english at moldev.com